What are the diagnostic criteria for primary immunodeficiency in children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Criteria for Primary Immunodeficiency in Children

Primary immunodeficiency (PID) should be suspected in children presenting with recurrent, severe, or unusual infections, and diagnosis is established through a stepwise clinical and laboratory evaluation guided by the specific pattern of infection and immune defect. 1

Clinical Warning Signs

The diagnosis begins with recognizing key clinical presentations that distinguish PID from normal childhood infections:

Most Discriminating Features

  • Need for IV antibiotics (most frequent warning sign at 88.5%) 2
  • Failure to thrive with chronic diarrhea 1
  • Family history of severe infections or unexplained infant deaths 1, 3
  • Persistent or recurrent thrush (present in 51% of cases) 2

Additional Red Flags

  • Two or more serious infections (pneumonia, meningitis, sepsis)
  • Infections with opportunistic organisms
  • Poor response to standard antibiotic therapy
  • Deep-seated abscesses or granuloma formation
  • Delayed separation of umbilical cord (>1 month)
  • Autoimmunity or lymphoproliferation 1

Critical caveat: The average diagnostic delay is 34.6 months 3, emphasizing the need for heightened clinical suspicion early in the disease course.

Pattern Recognition by Infection Type

The specific pattern of infections directly indicates which immune component is defective 1:

Recurrent Sinopulmonary Infections (Encapsulated Bacteria)

  • Suspect: Antibody deficiency (most common, accounting for 61.7% of cases) 3
  • Organisms: Streptococcus pneumoniae, Haemophilus influenzae

Opportunistic Infections + Failure to Thrive

  • Suspect: SCID (medical emergency)
  • Organisms: Pneumocystis jiroveci, disseminated viral infections, fungal infections
  • Key feature: Often detected on newborn screening via TREC analysis 1

Deep Abscesses with Granulomas

  • Suspect: Chronic granulomatous disease (phagocytic defect)
  • Organisms: Catalase-positive bacteria (Staphylococcus, Aspergillus) 1

Severe Mycobacterial/Salmonella Infections

  • Suspect: Mendelian susceptibility to mycobacterial disease (innate immune defect) 1

Recurrent Neisseria Infections

  • Suspect: Complement deficiency 1

Stepwise Laboratory Evaluation

The diagnostic approach follows a tiered system from screening to advanced testing 1:

Initial Screening Tests (First-Line)

Perform these in ALL suspected cases:

  1. Complete blood count with differential

    • Lymphopenia suggests SCID or combined immunodeficiency
    • Neutropenia indicates phagocytic defect
    • Thrombocytopenia with small platelets suggests Wiskott-Aldrich syndrome 1
  2. Quantitative immunoglobulins (IgG, IgA, IgM, IgE)

    • Panhypogammaglobulinemia indicates SCID or agammaglobulinemia
    • Selective reductions guide specific diagnoses 1
  3. Specific antibody titers

    • Post-vaccination responses (tetanus, diphtheria, pneumococcal)
    • Post-infection titers when applicable 1

Second-Line Tests (Based on Screening Results)

If antibody deficiency suspected:

  • Lymphocyte subset enumeration (CD19+ B cells)
  • Absent B cells → X-linked agammaglobulinemia (85% of agammaglobulinemia cases) 1
  • IgG subclass levels (only if total Ig normal but clinical suspicion high)
  • Important: Do NOT diagnose IgG subclass deficiency before age 10 for IgG4, and always confirm abnormal values on repeat testing 1

If combined/cellular deficiency suspected:

  • Lymphocyte proliferation assays (mitogens and antigens)
  • T-cell subset enumeration (CD3+, CD4+, CD8+)
  • NK cell cytotoxicity testing 1

If phagocytic defect suspected:

  • Neutrophil oxidative burst (dihydrorhodamine test for CGD)
  • Chemotaxis assays
  • CD18 expression for leukocyte adhesion deficiency 1

If complement deficiency suspected:

  • CH50 (classical pathway)
  • AH50 (alternative pathway)
  • Individual component levels 1

Advanced Testing (Third-Line)

Genetic testing is essential for:

  • Definitive diagnosis
  • Genetic counseling (especially with 45.7% consanguinity rate and 24.7% positive family history) 3
  • Identifying candidates for gene-specific therapies
  • Planning future pregnancies 1

Approach: Targeted gene sequencing based on phenotype, or whole-exome/genome sequencing when diagnosis unclear 1

Category-Specific Diagnostic Criteria

Severe Combined Immunodeficiency (SCID)

This is a medical emergency - outcomes dramatically improve with earliest intervention 1

Diagnostic criteria:

  • Profound lymphopenia (often <2,000/μL)
  • Absent T-cell proliferation
  • Panhypogammaglobulinemia
  • Absent or dysfunctional T cells
  • May be detected on newborn screening 1

Immediate action: Supportive care, antimicrobials, IgG replacement, urgent referral for hematopoietic stem cell transplantation 1

Antibody Deficiencies

Most common category (61.7% of cases) 3

X-linked agammaglobulinemia:

  • Absent/very low B cells (<2%)
  • IgG <200 mg/dL
  • Recurrent bacterial sinopulmonary infections after 6 months of age 1

Common variable immunodeficiency:

  • Reduction in ≥2 major immunoglobulin classes
  • Impaired specific antibody responses
  • Variable B-cell numbers
  • Onset typically after age 2 years 1

Specific antibody deficiency:

  • Normal total immunoglobulins
  • Impaired response to polysaccharide antigens (pneumococcal vaccine)
  • Recurrent infections despite normal Ig levels 1

Immunodeficiency Syndromes with Characteristic Features

Wiskott-Aldrich syndrome:

  • Thrombocytopenia with small platelets
  • Eczema
  • Recurrent infections
  • Autoimmunity 1

DiGeorge syndrome:

  • Hypocalcemic seizures (hypoparathyroidism)
  • Cardiac defects
  • Characteristic facies
  • Variable T-cell deficiency
  • May be detected on newborn SCID screening 1

Ataxia-telangiectasia:

  • Cerebellar ataxia
  • Oculocutaneous telangiectasias
  • Chronic sinopulmonary disease
  • Elevated alpha-fetoprotein 1

Common Pitfalls to Avoid

  1. Do not diagnose IgG subclass deficiency on a single measurement - requires confirmation and must be interpreted with age-appropriate norms 1

  2. Do not measure IgG4 before age 10 years - normally very low in young children 1

  3. Do not delay SCID evaluation - suspected SCID requires immediate expedited workup as these infants can die from infection at any time 1

  4. Do not overlook secondary causes - exclude immunosuppressive medications, HIV, malnutrition, and anatomic defects before diagnosing PID 1

  5. Do not rely solely on immunoglobulin levels - functional antibody testing is essential, as specific antibody deficiency presents with normal Ig levels 1

  6. Recognize that 2.5% of normal population will have one "low" IgG subclass by statistical definition - clinical correlation is mandatory 1

When to Refer

Immediate referral to immunology:

  • Any suspicion of SCID
  • Recurrent serious infections requiring hospitalization
  • Opportunistic infections
  • Abnormal newborn SCID screen
  • Positive family history with consanguinity (present in 80% of cases) 2

Consultation recommended:

  • Abnormal screening tests
  • Uncertainty in diagnosis or management
  • Consideration of immunoglobulin replacement therapy
  • Need for molecular diagnosis 1

The median diagnostic delay of 10.5 months 2 can be reduced through systematic application of these criteria and maintaining high clinical suspicion in children with the warning signs described above.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.